Deal-Making

SHL has partnered with Swiss CDMO ten23 to offer services to firms requiring sterile drug/device combination products.

Deal Making

Batavia Biosciences and Candel Therapeutics have partnered to develop multimodal biological immunotherapies to treat brain tumors.

Facilities & Capacity

CDMO White Raven is set to install Cytiva’s SA25 Aseptic Filling Workcell in a bid to reduce product contamination and increase efficiency.

Global Markets

WuXi Biologics has broken ground on a facility in Singapore, set to add 120,000 L of manufacturing capacity to the CDMO’s global network.

Global Markets

Brazilian Ministry of Health foundation Fiocruz says leveraging local manufacturing partners will cut the cost of CAR-T therapies by up to 90%.

Global Markets

WuXi Biologics has broken ground on a facility in Singapore, set to add 120,000 L of manufacturing capacity to the CDMO’s global network.

Regulations

CDMO AGC Bio will supply lentiviral vectors for Orchard Therapeutics’ metachromatic leukodystrophy (MLD) gene therapy, approved in the US this week.

Global Markets

Global biopharma lobbying organization BIO has forced WuXi AppTec to leave the group due to pressure from the US Congress.

Therapeutic Class

Brazilian Ministry of Health foundation Fiocruz says leveraging local manufacturing partners will cut the cost of CAR-T therapies by up to 90%.

Therapeutic Class

CDMOs must create tech platforms to drive efficiency and cut the cost of cell and gene therapies (CGTs), the sector said at a recent industry conference.

Upstream & Downstream Processing

MilliporeSigma has invested over €300 million ($326 million) to construct a bioprocessing production center in Daejeon, South Korea.

Upstream & Downstream Processing

Bio-Techne looks to the cell and gene therapy (CGT) sector to realign its financials, including the potential future acquisition of Wilson Wolf.